|
Volumn 256, Issue 4, 2009, Pages 651-656
|
Course of matrix metalloproteinase-9 isoforms after the administration of uric acid in patients with acute stroke : AAA proof-of-concept study
a
HOSPITAL CLÍNIC
(Spain)
|
Author keywords
Acute stroke; MMP 9; Oxidative stress; Thrombolysis; Uric acid
|
Indexed keywords
ALTEPLASE;
GELATINASE B;
URIC ACID;
ARTICLE;
BLOOD SAMPLING;
CLINICAL ARTICLE;
CONTROLLED STUDY;
FEMALE;
HUMAN;
HUMAN TISSUE;
MALE;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
STROKE;
STROKE PATIENT;
TREATMENT DURATION;
AGED;
ANTIOXIDANTS;
DOUBLE-BLIND METHOD;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INJECTIONS, INTRAVENOUS;
MALE;
MATRIX METALLOPROTEINASE 9;
MULTIVARIATE ANALYSIS;
NEUROPROTECTIVE AGENTS;
PILOT PROJECTS;
PROTEIN ISOFORMS;
RECOMBINANT PROTEINS;
SEVERITY OF ILLNESS INDEX;
STROKE;
TISSUE PLASMINOGEN ACTIVATOR;
TREATMENT OUTCOME;
URIC ACID;
|
EID: 65749108656
PISSN: 03405354
EISSN: 14321459
Source Type: Journal
DOI: 10.1007/s00415-009-0153-6 Document Type: Article |
Times cited : (34)
|
References (27)
|